Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Blood levels of heme oxygenase-1 versus bilirubin in patients with coronary artery disease.

Kishimoto Y, Niki H, Saita E, Ibe S, Umei T, Miura K, Ikegami Y, Ohmori R, Kondo K, Momiyama Y.

Clin Chim Acta. 2020 Jan 30;504:30-35. doi: 10.1016/j.cca.2020.01.030. [Epub ahead of print]

PMID:
32006543
2.

Associations between plasma nesfatin-1 levels and the presence and severity of coronary artery disease.

Ibe S, Kishimoto Y, Niki H, Saita E, Umei T, Miura K, Ikegami Y, Ohmori R, Kondo K, Momiyama Y.

Heart Vessels. 2019 Jun;34(6):965-970. doi: 10.1007/s00380-018-01328-3. Epub 2019 Jan 1.

PMID:
30599062
3.

Associations Between Plasma Betatrophin Levels and Coronary and Peripheral Artery Disease.

Niki H, Kishimoto Y, Ibe S, Saita E, Sasaki K, Miura K, Ikegami Y, Ohmori R, Kondo K, Momiyama Y.

J Atheroscler Thromb. 2019 Jun 1;26(6):573-581. doi: 10.5551/jat.46508. Epub 2018 Dec 4.

4.

Plasma Heme Oxygenase-1 Levels in Patients with Coronary and Peripheral Artery Diseases.

Kishimoto Y, Ibe S, Saita E, Sasaki K, Niki H, Miura K, Ikegami Y, Ohmori R, Kondo K, Momiyama Y.

Dis Markers. 2018 Aug 7;2018:6138124. doi: 10.1155/2018/6138124. eCollection 2018.

5.

Clinical usefulness of multiplex PCR-lateral flow for the diagnosis of orthopedic-related infections.

Minegishi Y, Uchiyama K, Sakurai K, Ibe S, Kanda H, Nihonyanagi S, Nakamura M, Ikeda S, Takaso M.

Mod Rheumatol. 2019 Sep;29(5):867-873. doi: 10.1080/14397595.2018.1514690. Epub 2018 Nov 5. Erratum in: Mod Rheumatol. 2019 Mar 26;:1.

PMID:
30126317
6.

Awareness, perceptions and intent to comply with the prospective malaria vaccine in parts of South Eastern Nigeria.

Chukwuocha UM, Okorie PC, Iwuoha GN, Ibe SN, Dozie IN, Nwoke BE.

Malar J. 2018 May 2;17(1):187. doi: 10.1186/s12936-018-2335-0.

7.

Change in mobility function and its causes in adults with cerebral palsy by Gross Motor Function Classification System level: A cross-sectional questionnaire study.

Himuro N, Mishima R, Seshimo T, Morishima T, Kosaki K, Ibe S, Asagai Y, Minematsu K, Kurita K, Okayasu T, Shimura T, Hoshino K, Suzuki T, Yanagizono T.

NeuroRehabilitation. 2018;42(4):383-390. doi: 10.3233/NRE-172340.

PMID:
29660955
8.

Low Levels of Plasma Osteoglycin in Patients with Complex Coronary Lesions.

Seki T, Saita E, Kishimoto Y, Ibe S, Miyazaki Y, Miura K, Ohmori R, Ikegami Y, Kondo K, Momiyama Y.

J Atheroscler Thromb. 2018 Nov 1;25(11):1149-1155. doi: 10.5551/jat.43059. Epub 2018 Mar 5.

9.

Low Plasma Levels of Fibroblast Growth Factor-21 in Patients with Peripheral Artery Disease.

Miyazaki Y, Saita E, Kishimoto Y, Ibe S, Seki T, Miura K, Suzuki-Sugihara N, Ikegami Y, Ohmori R, Kondo K, Momiyama Y.

J Atheroscler Thromb. 2018 Sep 1;25(9):821-828. doi: 10.5551/jat.41731. Epub 2018 Jan 24.

10.

Dynamic HIV-1 genetic recombination and genotypic drug resistance among treatment-experienced adults in northern Ghana.

Nii-Trebi NI, Brandful JAM, Ibe S, Sugiura W, Barnor JS, Bampoh PO, Yamaoka S, Matano T, Yoshimura K, Ishikawa K, Ampofo WK.

J Med Microbiol. 2017 Nov;66(11):1663-1672. doi: 10.1099/jmm.0.000621. Epub 2017 Oct 25.

PMID:
29068286
11.

Pioneering In Situ Recrystallization during Bead Milling: A Top-down Approach to Prepare Zeolite A Nanocrystals.

Anand C, Yamaguchi Y, Liu Z, Ibe S, Elangovan SP, Ishii T, Ishikawa T, Endo A, Okubo T, Wakihara T.

Sci Rep. 2016 Jul 5;6:29210. doi: 10.1038/srep29210.

12.

HIV-1 CRF01_AE and Subtype B Transmission Networks Crossover: A New AE/B Recombinant Identified in Japan.

Hosaka M, Fujisaki S, Masakane A, Hattori J, Shiino T, Gatanaga H, Shigemi U, Okazaki R, Hachiya A, Matsuda M, Ibe S, Iwatani Y, Yokomaku Y, Sugiura W; Japanese Drug Resistance HIV-1 Surveillance Network Team.

AIDS Res Hum Retroviruses. 2016 May;32(5):412-9. doi: 10.1089/aid.2015.0192. Epub 2015 Nov 16.

13.

Virological characteristics of hepatitis B genotype G/A2 recombination virus in Japan.

Tsuzuki Y, Watanabe T, Iio E, Fujisaki S, Ibe S, Kani S, Hamada-Tsutsumi S, Yokomaku Y, Iwatani Y, Sugiura W, Okuse C, Okumura A, Sato Y, Tanaka Y.

Hepatol Res. 2016 Jul;46(8):775-83. doi: 10.1111/hepr.12612. Epub 2015 Nov 19.

PMID:
26517979
14.

Principal Component Analysis of Conformation and Blood Marker Traits at Pre- and Post-Weaning Stages of Growth in F2 Crossbred Nigerian Indigenous X Landrace Pigs.

Okoro VM, Ogundu UE, Okani M, Oziri I, Eneowo O, Olisenekwu OT, Kadurumba O, Ogbuewu IP, Onyemauwa S, Ukwu HO, Ibe SN.

Anim Biotechnol. 2015;26(4):243-50. doi: 10.1080/10495398.2015.1014043.

PMID:
26158454
15.

Single step purification of recombinant proteins using the metal ion-inducible autocleavage (MIIA) domain as linker for tag removal.

Ibe S, Schirrmeister J, Zehner S.

J Biotechnol. 2015 Aug 20;208:22-7. doi: 10.1016/j.jbiotec.2015.05.016. Epub 2015 May 27.

PMID:
26026704
16.

Japanese external quality assessment program to standardize HIV-1 drug-resistance testing (JEQS2010 program) using in vitro transcribed RNA as reference material.

Yoshida S, Hattori J, Matsuda M, Okada K, Kazuyama Y, Hashimoto O, Ibe S, Fujisawa S, Chiba H, Tatsumi M, Kato S, Sugiura W.

AIDS Res Hum Retroviruses. 2015 Mar;31(3):318-25. doi: 10.1089/aid.2014.0059. Epub 2014 Dec 3.

17.

HIV-1 drug-resistance surveillance among treatment-experienced and -naïve patients after the implementation of antiretroviral therapy in Ghana.

Nii-Trebi NI, Ibe S, Barnor JS, Ishikawa K, Brandful JA, Ofori SB, Yamaoka S, Ampofo WK, Sugiura W.

PLoS One. 2013 Aug 19;8(8):e71972. doi: 10.1371/journal.pone.0071972. eCollection 2013.

18.

Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011.

Jahanbakhsh F, Hattori J, Matsuda M, Ibe S, Monavari SH, Memarnejadian A, Aghasadeghi MR, Mostafavi E, Mohraz M, Jabbari H, Kamali K, Keyvani H, Azadmanesh K, Sugiura W.

PLoS One. 2013 Apr 23;8(4):e61864. doi: 10.1371/journal.pone.0061864. Print 2013.

19.

Natto (fermented soybean) extract extends the adult lifespan of Caenorhabditis elegans.

Ibe S, Kumada K, Yoshida K, Otobe K.

Biosci Biotechnol Biochem. 2013;77(2):392-4. Epub 2013 Feb 7.

20.

The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α.

Miyamoto T, Nakayama EE, Yokoyama M, Ibe S, Takehara S, Kono K, Yokomaku Y, Pizzato M, Luban J, Sugiura W, Sato H, Shioda T.

PLoS One. 2012;7(10):e47757. doi: 10.1371/journal.pone.0047757. Epub 2012 Oct 19.

21.

Molecular epidemiology of HIV type 1 infection in Iran: genomic evidence of CRF35_AD predominance and CRF01_AE infection among individuals associated with injection drug use.

Jahanbakhsh F, Ibe S, Hattori J, Monavari SH, Matsuda M, Maejima M, Iwatani Y, Memarnejadian A, Keyvani H, Azadmanesh K, Sugiura W.

AIDS Res Hum Retroviruses. 2013 Jan;29(1):198-203. doi: 10.1089/AID.2012.0186. Epub 2012 Sep 25.

PMID:
22916738
22.

Cellular HIV-1 DNA levels in patients receiving antiretroviral therapy strongly correlate with therapy initiation timing but not with therapy duration.

Watanabe D, Ibe S, Uehira T, Minami R, Sasakawa A, Yajima K, Yonemoto H, Bando H, Ogawa Y, Taniguchi T, Kasai D, Nishida Y, Yamamoto M, Kaneda T, Shirasaka T.

BMC Infect Dis. 2011 May 24;11:146. doi: 10.1186/1471-2334-11-146.

23.

Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations.

Ibe S, Sugiura W.

Future Microbiol. 2011 Mar;6(3):295-315. doi: 10.2217/fmb.11.7. Review.

PMID:
21449841
24.

Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan.

Fujisaki S, Yokomaku Y, Shiino T, Koibuchi T, Hattori J, Ibe S, Iwatani Y, Iwamoto A, Shirasaka T, Hamaguchi M, Sugiura W.

J Clin Microbiol. 2011 Mar;49(3):1017-24. doi: 10.1128/JCM.02149-10. Epub 2011 Jan 19. Erratum in: J Clin Microbiol. 2012 Apr;50(4):1507.

25.

Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan.

Hattori J, Shiino T, Gatanaga H, Yoshida S, Watanabe D, Minami R, Sadamasu K, Kondo M, Mori H, Ueda M, Tateyama M, Ueda A, Kato S, Ito T, Oie M, Takata N, Hayashida T, Nagashima M, Matsuda M, Ibe S, Ota Y, Sasaki S, Ishigatsubo Y, Tanabe Y, Koga I, Kojima Y, Yamamoto M, Fujita J, Yokomaku Y, Koike T, Shirasaka T, Oka S, Sugiura W.

Antiviral Res. 2010 Oct;88(1):72-9. doi: 10.1016/j.antiviral.2010.07.008. Epub 2010 Aug 6.

PMID:
20692295
26.

HIV-2 CRF01_AB: first circulating recombinant form of HIV-2.

Ibe S, Yokomaku Y, Shiino T, Tanaka R, Hattori J, Fujisaki S, Iwatani Y, Mamiya N, Utsumi M, Kato S, Hamaguchi M, Sugiura W.

J Acquir Immune Defic Syndr. 2010 Jul;54(3):241-7. doi: 10.1097/QAI.0b013e3181dc98c1.

PMID:
20502347
27.

[Current topics on drug-resistant HIV in Japan].

Ibe S, Sugiura W.

Nihon Rinsho. 2010 Mar;68(3):476-9. Review. Japanese.

PMID:
20229793
28.

An 11-Year Surveillance of HIV Type 1 Subtypes in Nagoya, Japan.

Fujisaki S, Ibe S, Hattori J, Shigemi U, Fujisaki S, Shimizu K, Nakamura K, Yokomaku Y, Mamiya N, Utsumi M, Hamaguchi M, Kaneda T.

AIDS Res Hum Retroviruses. 2009 Jan;25(1):15-21. doi: 10.1089/aid.2008.0056.

PMID:
19182917
29.

Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naïve individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity.

Ibe S, Shigemi U, Sawaki K, Fujisaki S, Hattori J, Yokomaku Y, Mamiya N, Hamaguchi M, Kaneda T.

AIDS Res Hum Retroviruses. 2008 Aug;24(8):1121-5. doi: 10.1089/aid.2008.0090.

PMID:
18620491
30.

Trend of drug-resistant HIV type 1 emergence among therapy-naive patients in Nagoya, Japan: an 8-year surveillance from 1999 to 2006.

Ibe S, Hattori J, Fujisaki S, Shigemi U, Fujisaki S, Shimizu K, Nakamura K, Kazumi T, Yokomaku Y, Mamiya N, Hamaguchi M, Kaneda T.

AIDS Res Hum Retroviruses. 2008 Jan;24(1):7-14. doi: 10.1089/aid.2007.0129.

PMID:
18275342
31.

No observable correlation between central nervous system side effects and EFV plasma concentrations in Japanese HIV type 1-infected patients treated with EFV containing HAART.

Takahashi M, Ibe S, Kudaka Y, Okumura N, Hirano A, Suzuki T, Mamiya N, Hamaguchi M, Kaneda T.

AIDS Res Hum Retroviruses. 2007 Aug;23(8):983-7.

PMID:
17725414
32.

Performance and quality assurance of genotypic drug-resistance testing for human immunodeficiency virus type 1 in Japan.

Fujisaki S, Fujisaki S, Ibe S, Asagi T, Itoh T, Yoshida S, Koike T, Oie M, Konda M, Sadamasu K, Nagashima M, Gatanaga H, Matsuda M, Ueda M, Masakane A, Hata M, Mizogami Y, Mori H, Minami R, Okada K, Watanabe K, Shirasaka T, Oka S, Sugiura W, Kaneda T.

Jpn J Infect Dis. 2007 May;60(2-3):113-7.

33.

Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan.

Gatanaga H, Ibe S, Matsuda M, Yoshida S, Asagi T, Kondo M, Sadamasu K, Tsukada H, Masakane A, Mori H, Takata N, Minami R, Tateyama M, Koike T, Itoh T, Imai M, Nagashima M, Gejyo F, Ueda M, Hamaguchi M, Kojima Y, Shirasaka T, Kimura A, Yamamoto M, Fujita J, Oka S, Sugiura W.

Antiviral Res. 2007 Jul;75(1):75-82. Epub 2006 Dec 14.

PMID:
17194486
34.

Bacteriology of chronic discharging ears in Port Harcourt, Nigeria.

Wariso BA, Ibe SN.

West Afr J Med. 2006 Jul-Sep;25(3):219-22.

PMID:
17191422
35.

Quantitative SNP-detection method for estimating HIV-1 replicative fitness: application to protease inhibitor-resistant viruses.

Ibe S, Fujisaki S, Fujisaki S, Morishita T, Kaneda T.

Microbiol Immunol. 2006;50(10):765-72.

36.

Molecular pathology of Shprintzen-Goldberg syndrome.

Kosaki K, Takahashi D, Udaka T, Kosaki R, Matsumoto M, Ibe S, Isobe T, Tanaka Y, Takahashi T.

Am J Med Genet A. 2006 Jan 1;140(1):104-8; author reply 109-10. No abstract available.

PMID:
16333834
37.

Selective inhibitors of terminal deoxyribonucleotidyltransferase (TdT): baicalin and genistin.

Uchiyama Y, Tagami J, Kamisuki S, Kasai N, Oshige M, Chiku H, Ibe S, Koiwai O, Sugawara F, Sakaguchi K.

Biochim Biophys Acta. 2005 Oct 10;1725(3):298-304.

PMID:
16099107
38.

Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b.

Hata M, Suzuki M, Matsumoto M, Takahashi M, Sato K, Ibe S, Sakae K.

Antimicrob Agents Chemother. 2005 Feb;49(2):801-3.

39.

Delayed HIV-1 infection of CD4+ T lymphocytes from therapy-naïve patients demonstrated by quantification of HIV-1 DNA copy numbers.

Wada K, Nagai H, Hagiwara T, Ibe S, Utsumi M, Kaneda T.

Microbiol Immunol. 2004;48(10):767-72.

40.

Prevalence of infection and genotypes of GBV-C/HGV among homosexual men.

Hattori J, Ibe S, Nagai H, Wada K, Morishita T, Sato K, Utsumi M, Kaneda T.

Microbiol Immunol. 2003;47(10):759-63.

41.

Prevalence of drug-resistant human immunodeficiency virus type 1 in therapy-naive patients and usefulness of genotype testing.

Ibe S, Hotta N, Takeo U, Tawada Y, Mamiya N, Yamanaka K, Utsumi M, Kaneda T.

Microbiol Immunol. 2003;47(7):499-505.

42.

Terminal deoxynucleotidyltransferase forms a ternary complex with a novel chromatin remodeling protein with 82 kDa and core histone.

Fujita K, Shimazaki N, Ohta Y, Kubota T, Ibe S, Toji S, Tamai K, Fujisaki S, Hayano T, Koiwai O.

Genes Cells. 2003 Jun;8(6):559-71.

44.
45.

Tumor rejection by disturbing tumor stroma cell interactions.

Ibe S, Qin Z, Schüler T, Preiss S, Blankenstein T.

J Exp Med. 2001 Dec 3;194(11):1549-59.

46.

Terminal deoxynucleotidyltransferase is negatively regulated by direct interaction with proliferating cell nuclear antigen.

Ibe S, Fujita K, Toyomoto T, Shimazaki N, Kaneko R, Tanabe A, Takebe I, Kuroda S, Kobayashi T, Toji S, Tamai K, Yamamoto H, Koiwai O.

Genes Cells. 2001 Sep;6(9):815-24.

47.

Terminal deoxynucleotidyltransferase directly interacts with a novel nuclear protein that is homologous to p65.

Yamashita N, Shimazaki N, Ibe S, Kaneko R, Tanabe A, Toyomoto T, Fujita K, Hasegawa T, Toji S, Tamai K, Yamamoto H, Koiwai O.

Genes Cells. 2001 Jul;6(7):641-52.

48.

T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice.

Schüler T, Qin Z, Ibe S, Noben-Trauth N, Blankenstein T.

J Exp Med. 1999 Mar 1;189(5):803-10.

49.

B cells inhibit induction of T cell-dependent tumor immunity.

Qin Z, Richter G, Schüler T, Ibe S, Cao X, Blankenstein T.

Nat Med. 1998 May;4(5):627-30.

PMID:
9585241
50.

Drug susceptibility profile of Salmonella typhi blood isolates in Port Harcourt, Nigeria.

Ibe SN, Wariso BA.

West Afr J Med. 1996 Oct-Dec;15(4):219-22.

PMID:
9020600

Supplemental Content

Support Center